A multicenter characterization of hepatitis associated with immune checkpoint inhibitors

Immune checkpoint inhibitors (ICI) predispose patients to immune-related adverse events (irAEs). Although hepatitis is a potentially lethal toxicity, the timing and outcomes have not been well described. In this retrospective study, patients from six international institutions were included if they...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrinely, J. Randall, McGuigan, Ben, Chandra, Sunandana, Fenton, Sarah E., Chowdhary, Akansha, Kennedy, Lucy B., Mooradian, Meghan J., Palmeri, Marisa, Portal, Daniella, Horst, Sara N., Scoville, Elizabeth A., Long, Georgina V., Shi, Chanjuan, Mehnert, Janice M., Sullivan, Ryan J., Salama, April K., Sosman, Jeffrey A., Menzies, Alexander M., Johnson, Douglas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889227/
https://www.ncbi.nlm.nih.gov/pubmed/33628621
http://dx.doi.org/10.1080/2162402X.2021.1875639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889227/
https://www.ncbi.nlm.nih.gov/pubmed/33628621
http://dx.doi.org/10.1080/2162402X.2021.1875639

Ejemplares similares